FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -25.0% | 2,854 | +68.1% | 0.00% | – |
| Q2 2023 | $8 | +60.0% | 1,698 | +83.8% | 0.00% | – |
| Q1 2023 | $5 | -75.0% | 924 | -53.3% | 0.00% | – |
| Q4 2022 | $20 | -99.9% | 1,979 | +118.0% | 0.00% | – |
| Q3 2022 | $20,000 | -4.8% | 908 | +6.3% | 0.00% | – |
| Q2 2022 | $21,000 | +2000.0% | 854 | +5237.5% | 0.00% | – |
| Q1 2022 | $1,000 | – | 16 | +300.0% | 0.00% | – |
| Q4 2021 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |